Skip to content
Zerafil Dosing
Response Assessment
Response Assessment: Asthma
Response Assessment: Urticaria
Response Assessment: CRSwNP
Treatment Initiation
Treatment Initiation: Asthma
Treatment Initiation: Urticaria
Treatment Initiation: CRSwNP
Control Test
Control Test: Asthma (ACT)
Control Test: Urticaria (UCT)
Control Test: Sino-Nasal Outcome Test (SNOT-22)
Zerafil Dosing
Response Assessment
Response Assessment: Asthma
Response Assessment: Urticaria
Response Assessment: CRSwNP
Treatment Initiation
Treatment Initiation: Asthma
Treatment Initiation: Urticaria
Treatment Initiation: CRSwNP
Control Test
Control Test: Asthma (ACT)
Control Test: Urticaria (UCT)
Control Test: Sino-Nasal Outcome Test (SNOT-22)
Contact us
Treatment Initiation: Urticaria
"
*
" indicates required fields
Is the patient’s disease adequately controlled with the current treatment?
*
Yes
No
Has the patient been treated with second-generation antihistamines (sgAH) at the standard dose for 2–4 weeks?
*
Yes
No
Has the patient been treated with up-dosed second-generation antihistamines (up to 4× the standard dose) for 2–4 weeks?
*
Yes
No
Hidden
SUM
